Sök artiklar i SveMed+

Observera: SveMed+ upphör att uppdateras!



Kardiotoxicitet relativt vanligt vid cancerbehandling
Engelsk titel: Cardiotoxicity relatively common in cancer treatment Läs online Författare: Buhlmann Lerjen, Eva ; Hubbert, Laila ; Papakonstantinou, Antroula ; Hedayati, Elham ; Linde, Cecilia ; Månsson Broberg, Agneta Språk: Swe Antal referenser: 32 Dokumenttyp: Översikt UI-nummer: 16087668

Tidskrift

Läkartidningen 2016;113(26-27)1216-9 ISSN 0023-7205 E-ISSN 1652-7518 KIBs bestånd av denna tidskrift Denna tidskrift är expertgranskad (Peer-Reviewed)

Sammanfattning

Modern cancer therapy has noticeably improved the prognosis for various cancer diseases, but cardiovascular side effects are not uncommon, both in short and long term. The individual patient’s cardiovascular risk profile affects the risk of developing side effects. Potential underestimation of this risk can lead to life-long severe cardiac disease for a patient that has been cured from cancer. Overestimation of the risk can lead to withdrawal of life-saving cancer treatment because of potentially reversible or mild cardiac side effects. A multidisciplinary approach will lead to better handling of cardio-oncologic patients.